WHAT DOES ABBV-744 IN CLINICAL TRIALS FOR NON-SMALL CELL LUNG CANCER (NSCLC) MEAN?

In Phase A, members will receive various doses and schedules of oral ABBV-744 pill to establish Risk-free dosing regimen. Additional contributors will probably be enrolled at the discovered monotherapy dosign program. In Section B, participants will acquire oral ruxolitinib and ABBV-744 is going to be offered as "include-on" therapy. In Phase C, in